Cart
sales@molnova.com
SKLB 610
CAS No. 1125780-41-7
SKLB 610( SKLB610 | SKLB 610 | SKLB-610 )
Catalog No. M10442 CAS No. 1125780-41-7
SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 58 | In Stock |
|
| 10MG | 111 | In Stock |
|
| 25MG | 210 | In Stock |
|
| 50MG | 312 | In Stock |
|
| 100MG | 462 | In Stock |
|
| 200MG | 656 | In Stock |
|
| 500MG | 972 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSKLB 610
-
NoteResearch use only, not for human use.
-
Brief DescriptionSKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR.
-
DescriptionSKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 μM in biochemical kinase assays.
-
In Vitro——
-
In Vivo——
-
SynonymsSKLB610 | SKLB 610 | SKLB-610
-
PathwayAngiogenesis
-
TargetFGFR
-
RecptorFGFR| PDGFR| VEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1125780-41-7
-
Formula Weight415.37
-
Molecular FormulaC21H16F3N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(NC)C1=NC=CC(OC2=CC=C(NC(C3=CC=CC(C(F)(F)F)=C3)=O)C=C2)=C1
-
Chemical NameN-methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shah A, Mangaonkar A. Ann PharmacOthers. 2015 Jul 16.
molnova catalog
related products
-
EBE-A22
EBE-A22 is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.
-
GSK2830371
GSK2830371 is an orally active, allosteric Wip1 phosphatase inhibitor with IC50 of 6 nM.
-
FGF-401
FGF-401 (NVP-FGF401, Roblitinib, FGF401)?is a first-in-class, potent, highly selective FGFR4 inhibitor with IC50 of 1.1 nM.
